Eli Lilly And Co vs McCormick & Company, Incorporated — how do they compare? Eli Lilly And Co trades at $1,213.85 (market cap $1.08T), while McCormick & Company, Incorporated trades at $52.75 (market cap $14.22B). The key difference: Eli Lilly And Co is far larger — about 75.9× McCormick & Company, Incorporated's market cap, and McCormick & Company, Incorporated pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| LLY | MKC | |
|---|---|---|
Market Cap | $1.08T | $14.22B |
Sector | Health | Consumer Staples |
52-Week High | $1.24K | $72.26 |
52-Week Low | $639.43 | $45.60 |
Enterprise Value | $1.13T | $18.82B |
Dividend Yield | 0.57% | 3.63% |
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →